Cetek Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Cetek General Information

Description

Developer of cancer therapeutics. The company develops technology which enhances bility to discover valuable "hits" in synthetic compound libraries, combinatorial mixtures and natural product extracts. The company focuses on drug screening with a core technology based on a proprietary capillary electrophoresis screening (CE Assay) technology.

Contact Information

Website
www.cetek.com
Formerly Known As
H & K
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 260 Cedar Hill Street
  • Marlborough, MA 01752
  • United States
+1 (508)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Wyeth
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 260 Cedar Hill Street
  • Marlborough, MA 01752
  • United States
+1 (508)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cetek Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition Completed Generating Revenue
5. Later Stage VC 03-Jan-2006 Completed Generating Revenue
4. Early Stage VC (Series A) 07-Apr-2004 Completed Product Development
3. Early Stage VC 19-Feb-2003 Completed Product Development
2. Early Stage VC 12-Oct-2001 $14M $28M Completed Product Development
1. Early Stage VC $14M $14M Completed
To view Cetek’s complete valuation and funding history, request access »

Cetek Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Cetek Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1421360-A1 Microscale affinity purification system Inactive 03-Aug-2001
CA-2456078-A1 Microscale affinity purification system Inactive 03-Aug-2001
EP-1340068-A2 High throughput capillary electrophoresis system Inactive 01-Dec-2000
CA-2430086-A1 High throughput capillary electrophoresis system Inactive 01-Dec-2000
EP-1720011-A1 High throughput capillary electrophoresis system Inactive 01-Dec-2000 G01N27/44721
To view Cetek’s complete patent history, request access »

Cetek Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gainesbourgh Investments Venture Capital Minority
Stata Capital Partners Venture Capital Minority
Stata Venture Partners Venture Capital Minority
Ventry Industries Holding Company Minority
To view Cetek’s complete investors history, request access »

Ready to get started?

Request a free trial

Cetek FAQs

  • When was Cetek founded?

    Cetek was founded in 1998.

  • Where is Cetek headquartered?

    Cetek is headquartered in Marlborough, MA.

  • What industry is Cetek in?

    Cetek’s primary industry is Drug Discovery.

  • Is Cetek a private or public company?

    Cetek is a Private company.

  • What is Cetek’s current revenue?

    The current revenue for Cetek is .

  • How much funding has Cetek raised over time?

    Cetek has raised $60.2M.

  • Who are Cetek’s investors?

    Gainesbourgh Investments, Stata Capital Partners, Stata Venture Partners, and Ventry Industries have invested in Cetek.

  • Who acquired Cetek?

    Cetek was acquired by Wyeth.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »